Issue Royalty. Stanford and ImmuMetrix acknowledge and agree that in consideration of the grant of the license hereunder, ImmuMetrix has paid to Stanford a noncreditable, nonrefundable license issue royalty of $[***] upon signing the PCR Agreement and a noncreditable, nonrefundable license issue royalty of $[***] upon signing the Sequencing Agreement and no addition issue royalty, except as set forth in Section 7.16 hereof, shall be due upon the signing of this Restated Agreement.
Appears in 2 contracts
Samples: Agreement and Plan of Merger (CareDx, Inc.), Common Stock Purchase Agreement (CareDx, Inc.)
Issue Royalty. Stanford and ImmuMetrix acknowledge and agree that in consideration of the grant of the license hereunder, ImmuMetrix has paid to Stanford a noncreditable, nonrefundable license issue royalty of $[***] 20,000 upon signing the PCR Agreement and a noncreditable, nonrefundable license issue royalty of $[***] 20,000 upon signing the Sequencing Agreement and no addition issue royalty, except as set forth in Section 7.16 hereof, shall be due upon the signing of this Restated Agreement.
Appears in 2 contracts
Samples: Common Stock Purchase Agreement (CareDx, Inc.), Agreement and Plan of Merger (CareDx, Inc.)
